[Results and considerations on the treatment of peripheral vascular diseases with a new product compounded by the salification of p-hydroxyphenylbutazone with 2-beta-hydroxyphenethylaminopyridine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008205:Lymphangitis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014652:Vascular Diseases / Q000188:drug therapy*
D000700:Analgesics; D000893:Anti-Inflammatory Agents
Risultati e considerazioni sul trattamento delle vasculopatie periferiche con un nuovo prodotto derivante dalla salificazione del p-idrossifenilbutazone con la 2-beta-idrossifenetilaminopiridina.